ESH – European Society of Hypertension
Teaching Seminars - Webcast Hypertension and Cardiovascular ProtectionPortfolio Resonance > progettazione e realizzazione Siti web > ESH – European Society of Hypertension
Webcasts interattivi ESH
2011 – 2012: realizzazione di webcast per il sito web di ESH – European Society of Hypertension, per conto di Infomedica (www.infomedica.com), che ha fornito tutti i contenuti. I webcasts sono stati realizzati in Flash, sincronizzando via codice ActionScript le diapositive e i testi ai cuepoint (punti specifici del video ad un determinato valore di tempo).
Alcuni webcast, dall’archivio online di Infomedica (richiedono FlashPlayer).
21th European Meeting on Hypertension and Cardiovascular Protection
June 17-20, 2011 – Milan, Italy
Teaching Session 1: Risk factor control
- Diabetes
P.M. Nilsson (Malmö, Sweden) - Obesity and other metabolic factors
M.H. Olsen (Odense, Denmark) - Stress: a risk for cardiovascular diseases?
P. van de Borne (Brussels, Belgium) - Home Blood Pressure. New ESH guidelines
G. Parati (Milan, Italy)
Teaching Session 2: Hypertension related problems and their management
- Erectile dysfunction
W. Kiowski (Zürich, Switzerland) - Erectile dysfunction – Therapeutic agents: Bad and Good
P.A. van Zwieten (Amsterdam, Netherlands) - Sport and hypertension
C. Giannattasio (Milan, Italy) - Blood pressure variability: a new life?
D.L. Clement (Ghent, Belgium) - Statins and hypertension: to be given to all patients?
H.A. Struijker-Boudier (Maastricht, Netherlands)
22nd European Meeting on Hypertension and Cardiovascular Protection
April 26-29, 2012 – London, U.K.
Teaching Session 1: Hypertension Related Problems: Their Management and Future Prospectives
- Hypertension and Heart Failure: what drugs to choose?
E. Agabiti Rosei (Brescia, Italy) - What is new in the management of hypertension in pregnancy
R. Cifková (Prague, Czech Republic) - Where is the hypertension research going in 2012?
H. Haller (Hannover, Germany)
Teaching Session 2: Concomitant Questions in the Treatment of Hypertension
- New developments in the field of renin and aldosterone antagonists
M. Burnier (Lausanne, Switzerland) - Renovascular Hypertension 2012: Diagnosis and treatment
P.F. Plouin (Paris, France) - Renal Denervation: a clinician’s standpoint
D.L. Clement (Ghent, Belgium)
Teaching Session 3: New Ideas on the Use of Antihypertensive Agents
- How useful was the discovery of the human genome for the management of hypertension
A.F. Dominiczak (Glasgow, United Kingdon) - Metabolic aspects of hypertensive drugs
H.A. Struijker-Boudier (Maastricht, Netherlands) - Hypertension in children and adolescents
E. Lurbe (Valencia, Spain)